Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Simply Wall StDec 21 20:20

Express News | Marinus Pharmaceuticals Inc - on Dec 6, Receives Nasdaq Notice for Minimum Bid Price Deficiency

BreakingsDec 11 05:43

US$1.86: That's What Analysts Think Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Is Worth After Its Latest Results

Yahoo FinanceNov 15 18:49

Marinus Pharmaceuticals Price Target Maintained With a $2.00/Share by HC Wainwright & Co.

Dow JonesNov 14 19:57 · Ratings

D. Boral Capital Maintains Buy on Marinus Pharma, Maintains $3 Price Target

BenzingaNov 14 07:04 · Ratings

JMP Securities Maintains Marinus Pharmaceuticals(MRNS.US) With Hold Rating

Futu NewsNov 14 00:31 · Ratings